A
MRNA icon

AlphaQuest’s Moderna MRNA Stock Holding History

AlphaQuest’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-841
Closed -$24.8K – 1270
2025
Q4 		$24.8K Sell
841
-35,300
-98% -$959K ﹤0.01% 2074
2025
Q3 		$934K Buy
36,141
+13,096
+57% +$365K 0.06% 460
2025
Q2 		$636K Buy
23,045
+18,460
+403% +$486K 0.06% 490
2025
Q1 		$130K Buy
4,585
+2,572
+128% +$91.3K 0.01% 1189
2024
Q4 		$83.7K Sell
2,013
-2,554
-56% -$122K 0.01% 1148
2024
Q3 		$305K Buy
4,567
+3,223
+240% +$296K 0.03% 893
2024
Q2 		$160K Buy
1,344
+1,333
+12,118% +$169K 0.02% 819
2024
Q1 		$1.17K Buy
+11
New +$1.11K ﹤0.01% 1325

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return